We are live on
!
Find out more
NCM
Nantahala Capital Management Portfolio holdings
AUM
$2.72B
1-Year Est. Return
121.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.08%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.03B
AUM Growth
-$271M
(-21%)
Cap. Flow
-$280M
Cap. Flow
% of AUM
-27.07%
Top 10 Holdings %
Top 10 Hldgs %
51.2%
Holding
145
New
21
Increased
20
Reduced
48
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
The Bancorp
TBBK
|
+$12.6M |
| 2 |
Cytokinetics
CYTK
|
+$5.52M |
| 3 |
Dyne Therapeutics
DYN
|
+$4.89M |
| 4 |
LYRA
LYRA THERAPEUTICS INC
LYRA
|
+$4.82M |
| 5 |
Amylyx Pharmaceuticals
AMLX
|
+$4.44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TA
TravelCenters of America LLC
TA
|
+$51.7M |
| 2 |
APEN
Apollo Endosurgery, Inc.
APEN
|
+$45.4M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$24M |
| 4 |
Travel + Leisure Co
TNL
|
+$23.3M |
| 5 |
Syndax Pharmaceuticals
SNDX
|
+$13.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 41.04% |
| 2 | Financials | 9.2% |
| 3 | Consumer Discretionary | 9.01% |
| 4 | Communication Services | 6.73% |
| 5 | Industrials | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
PUT
iShares Russell 2000 ETF
IWM
$79.1B
| $131M | 12.68% |
700,000
-310,000
| -31% | -$55.3M |
|
2
Establishment Labs
ESTA
$2.71B
| $126M | 12.23% |
1,843,234
-28,926
| -2% | -$2M |
|
3
Pathward Financial
CASH
$1.88B
| $65.1M | 6.29% |
1,403,707
+63,772
| +5% | +$2.86M |
|
4
IMAX
IMAX
$2.67B
| $50M | 4.84% |
2,944,877
-108,818
| -4% | -$2.07M |
|
5
uniQure
QURE
$2.78B
| $32.6M | 3.16% |
2,848,984
-221,377
| -7% | -$4.19M |
|
6
Luxfer Holdings
LXFR
$456M
| $31.6M | 3.06% |
2,223,439
-240,849
| -10% | -$3.69M |
|
7
Immatics
IMTX
$1.23B
| $26.4M | 2.55% |
2,284,895
-463,632
| -17% | -$4.33M |
|
8
Red Violet
RDVT
$957M
| $26.1M | 2.52% |
1,267,614
-43,190
| -3% | -$806K |
|
9
Hilton Grand Vacations
HGV
$4.04B
| $20M | 1.94% |
440,879
+30,679
| +7% | +$1.37M |
|
10
Keros Therapeutics
KROS
$197M
| $20M | 1.93% |
497,161
-245,658
| -33% | -$10.8M |
|
11
Viemed Healthcare
VMD
$447M
| $16.9M | 1.63% |
1,728,495
+135,701
| +9% | +$1.38M |
|
|
LYRA
12
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $16.3M | 1.57% |
79,151
+34,734
| +78% | +$4.82M |
|
13
Bioventus
BVS
$889M
| $16.2M | 1.57% |
5,617,626
+444,157
| +9% | +$852K |
|
14
The RMR Group
RMR
$335M
| $16.2M | 1.57% |
699,330
-122,577
| -15% | -$2.86M |
|
|
RDNW
15
RideNow Group
RDNW
$256M
| $15.7M | 1.52% |
1,271,351
-293,643
| -19% | -$2.74M |
|
16
Codexis
CDXS
$158M
| $14.1M | 1.36% |
5,035,663
-115,896
| -2% | -$375K |
|
|
GDEN
17
DELISTED
Golden Entertainment
GDEN
| $13.9M | 1.34% |
332,063
-21,346
| -6% | -$894K |
|
18
Peloton Interactive
PTON
$2.85B
| $13.6M | 1.31% |
1,762,311
-694,932
| -28% | -$5.9M |
|
|
19
The Bancorp
TBBK
$2.81B
| $13.3M | 1.29% |
+407,946
| New | +$12.6M |
|
20
CALL
RH
RH
$3.33B
| $13.2M | 1.27% |
40,000
| – | – |
|
21
MediaAlpha
MAX
$746M
| $11.8M | 1.14% |
1,142,985
+55,992
| +5% | +$506K |
|
22
DHI Group
DHX
$177M
| $11.6M | 1.12% |
3,030,198
-384,113
| -11% | -$1.42M |
|
|
23
iShares Russell 2000 ETF
IWM
$79.1B
| $10.6M | 1.03% |
56,672
-134,368
| -70% | -$24M |
|
24
America's Car Mart
CRMT
$25.9M
| $10.6M | 1.02% |
106,178
+42,108
| +66% | +$3.65M |
|
|
AUTL
25
Autolus Therapeutics
AUTL
$389M
| $10.2M | 0.98% |
4,272,203
-3,419,610
| -44% | -$8.11M |
|
Similar funds
TAM
FNF
CA
XL
NB
MASUI
PA
BCM
Nantahala Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Nantahala Capital Management held 145 positions worth $1.03B, down 21% from $1.31B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Nantahala Capital Management withdrew a net $280M in Q2 2023, closing 21 positions and reducing 48 holdings. Its most notable exit was TravelCenters of America LLC, an estimated $51.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 38% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Nantahala Capital Management opened a new position in The Bancorp worth $13.3M.
- Nantahala Capital Management's largest Q2 2023 buy was The Bancorp: 407,946 shares worth $13.3M.
- Nantahala Capital Management added most to Cytokinetics in Q2 2023, an estimated $5.52M increase.
- Nantahala Capital Management's biggest Q2 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $24M.
- Nantahala Capital Management fully exited TravelCenters of America LLC in Q2 2023, selling an estimated $51.7M.
- Nantahala Capital Management's ten largest holdings make up 51% of its $1.03B portfolio in Q2 2023.
- Nantahala Capital Management opened 21 new positions and closed 21 in Q2 2023.
- Nantahala Capital Management's portfolio value fell 21% quarter-over-quarter to $1.03B.
Based on Nantahala Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.